MTS Accelerates Growth With New Actuator Technologies

EDEN PRAIRIE, Minn., April 27, 2018 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced availability of new hydraulic actuator finishing technologies that are driving growth through improved product performance and reduced environmental impact. Customers have responded favorably to MTS’ new actuator finishing technologies, resulting in... Read more

MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection

News Release April 27, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection Highly sensitive optical system based on patented technology unique to MilliporeSigma’s Amnis® flow cytometers Configurable, 7-laser capacity to meet researchers’ evolving needs Laser upgrades quickly performed in lab with no... Read more

Ready-to-use, synthetic surface cultureware for human induced pluripotent stem cells (hiPSCs) coming to market

Hamburg, April 2018 The major aim during the multi-passage cultivation of pluripotent stem cells (PSCs) is to preserve their differentiation and growth potential. Here, the proper selection of a defined culture system that consists of a growth surface and culture medium is crucial. The commonly used biological coating materials for PSC expansion are based on... Read more

New Entry-Level, Automated Titrators Accelerate Laboratory Productivity

The Thermo Scientific Orion Star T900 Series is designed to automate QC/QA processes and boost efficiency WALTHAM, Mass., April 26, 2018 /PRNewswire/ — A new series of entry-level, automated potentiometric laboratory-grade titrators has been designed to make titrations easier, more reliable and more accurate than manual alternatives, across a wide range of QC/QA applications within food... Read more

BD Launches BD FACSymphony™ S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types

FRANKLIN LAKES, N.J., April 26, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform... Read more

The Global Metabolomics Market (Forecast: 2017–2022)—Top Down Analytics

LOS ANGELES, April 25, 2018 (GLOBE NEWSWIRE) — Top-Down Analytics (TDA), a Los Angeles-  based market research and management consulting firm has announced a new market report entitled Metabolomics 2018: Charged with Massive Potential. Over the past five years, the market for metabolomics research has increased dramatically, with LC/MS and NMR leading the charge in... Read more

Bruker Introduces Contour LS-K 3D Optical Profiler

LightSpeed Focus Variation Technology Provides Fast, Extremely Accurate Metrology STUTTGART, Germany, April 24, 2018 /PRNewswire/ — At the 32nd Control 2018 international trade fair for quality assurance, Bruker today announced the release of its new Contour LS-K3D optical profiler with LightSpeed™ focus variation technology. This technique uses optimized focusing with advanced algorithms to construct 3D surface... Read more

New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis

Basel, 23 April 2018 New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis Four years of continuous treatment with OCREVUS showed a sustained reduction in underlying disease activity in relapsing MS (RMS) in analysis from the open-label extension period Additional analyses show OCREVUS delayed cognitive... Read more

New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis

Basel, 23 April 2018 New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis Four years of continuous treatment with OCREVUS showed a sustained reduction in underlying disease activity in relapsing MS (RMS) in analysis from the open-label extension period Additional analyses show OCREVUS delayed cognitive... Read more